CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $700,903 | -39.5% | 417,204 | +1.9% | 0.00% | – |
| Q2 2023 | $1,158,967 | -66.7% | 409,529 | -42.2% | 0.00% | -100.0% |
| Q1 2023 | $3,480,292 | -55.6% | 708,817 | -2.9% | 0.00% | -50.0% |
| Q4 2022 | $7,844,024 | +15.6% | 730,356 | +0.7% | 0.00% | 0.0% |
| Q3 2022 | $6,788,000 | +11.5% | 725,246 | +8.8% | 0.00% | +100.0% |
| Q2 2022 | $6,089,000 | -9.1% | 666,879 | +21.0% | 0.00% | 0.0% |
| Q1 2022 | $6,697,000 | -3.4% | 551,223 | -3.2% | 0.00% | 0.0% |
| Q4 2021 | $6,933,000 | -24.2% | 569,197 | -3.8% | 0.00% | -50.0% |
| Q3 2021 | $9,142,000 | +7.7% | 591,702 | -0.5% | 0.00% | +100.0% |
| Q2 2021 | $8,486,000 | -20.4% | 594,647 | +21.1% | 0.00% | -50.0% |
| Q1 2021 | $10,657,000 | +33.8% | 490,892 | -6.8% | 0.00% | 0.0% |
| Q4 2020 | $7,967,000 | +17.5% | 526,543 | -1.2% | 0.00% | +100.0% |
| Q3 2020 | $6,782,000 | -30.2% | 532,941 | -6.3% | 0.00% | -50.0% |
| Q2 2020 | $9,723,000 | +38.8% | 568,673 | +7.2% | 0.00% | 0.0% |
| Q1 2020 | $7,004,000 | -16.6% | 530,311 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $8,399,000 | -13.4% | 521,342 | -1.7% | 0.00% | 0.0% |
| Q3 2019 | $9,696,000 | +5.5% | 530,377 | +24.0% | 0.00% | 0.0% |
| Q2 2019 | $9,194,000 | +10.0% | 427,656 | +0.4% | 0.00% | 0.0% |
| Q1 2019 | $8,359,000 | +51.6% | 426,008 | +0.4% | 0.00% | 0.0% |
| Q4 2018 | $5,515,000 | -45.6% | 424,170 | +0.2% | 0.00% | 0.0% |
| Q3 2018 | $10,140,000 | +57.3% | 423,358 | +25.8% | 0.00% | 0.0% |
| Q2 2018 | $6,446,000 | +62.8% | 336,581 | +5.2% | 0.00% | +100.0% |
| Q1 2018 | $3,959,000 | +2.2% | 319,838 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $3,873,000 | -13.7% | 316,434 | -3.5% | 0.00% | 0.0% |
| Q3 2017 | $4,487,000 | -11.4% | 327,766 | -0.4% | 0.00% | 0.0% |
| Q2 2017 | $5,064,000 | +11.7% | 329,070 | +33.5% | 0.00% | 0.0% |
| Q1 2017 | $4,533,000 | +111.5% | 246,517 | +6.8% | 0.00% | 0.0% |
| Q4 2016 | $2,143,000 | +8.0% | 230,727 | -2.9% | 0.00% | 0.0% |
| Q3 2016 | $1,984,000 | +90.4% | 237,624 | +9.7% | 0.00% | – |
| Q2 2016 | $1,042,000 | -26.9% | 216,644 | -5.5% | 0.00% | – |
| Q1 2016 | $1,426,000 | -63.4% | 229,293 | -0.7% | 0.00% | -100.0% |
| Q4 2015 | $3,893,000 | +35.1% | 230,879 | +14.5% | 0.00% | 0.0% |
| Q3 2015 | $2,882,000 | +239.1% | 201,670 | +188.1% | 0.00% | – |
| Q2 2015 | $850,000 | +32.6% | 69,992 | +9.8% | 0.00% | – |
| Q1 2015 | $641,000 | +0.8% | 63,761 | 0.0% | 0.00% | – |
| Q4 2014 | $636,000 | +22.5% | 63,761 | +3.2% | 0.00% | – |
| Q3 2014 | $519,000 | -45.8% | 61,791 | +9.9% | 0.00% | – |
| Q2 2014 | $957,000 | +153.8% | 56,243 | +178.1% | 0.00% | – |
| Q1 2014 | $377,000 | – | 20,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |